Published in Dermatoendocrinol on May 01, 2009
Steroidogenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol (2013) 1.71
The role of inflammation in the pathology of acne. J Clin Aesthet Dermatol (2013) 0.99
An innovative approach to the topical treatment of acne. Clin Cosmet Investig Dermatol (2015) 0.75
Could thoracoscopic sympathicotomy for hyperhidrosis also improve acne vulgaris? Kardiochir Torakochirurgia Pol (2014) 0.75
The blemishes of modern society? Acne prevalence in the Dogon of Mali. Evol Med Public Health (2016) 0.75
Neuroendocrinology of the skin. Endocr Rev (2000) 3.34
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98
The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res (1996) 1.94
Acne and sebaceous gland function. Clin Dermatol (2004) 1.87
Inflammatory events are involved in acne lesion initiation. J Invest Dermatol (2003) 1.83
Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology (1998) 1.71
CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab (2004) 1.64
Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab (2002) 1.46
Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology (2003) 1.46
CRH stimulates POMC activity and corticosterone production in dermal fibroblasts. J Neuroimmunol (2005) 1.42
What is the pathogenesis of acne? Exp Dermatol (2005) 1.40
Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol Today (1997) 1.37
Acne vulgaris. Lancet (1998) 1.25
Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med (Berl) (2005) 1.23
Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci U S A (2002) 1.22
Pathogenesis of acne. Med Electron Microsc (2001) 1.15
Potential mechanism of skin response to stress. Int J Dermatol (1996) 1.13
Corticotropin-releasing hormone-binding protein: biochemistry and function from fishes to mammals. J Endocrinol (2002) 1.09
Characterization of corticotropin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metab (1998) 1.06
Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol (1992) 1.06
Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol (1996) 1.04
Neuroendocrine regulation of sebocytes -- a pathogenetic link between stress and acne. Exp Dermatol (2004) 1.01
Corticotropin-releasing hormone and inflammation. Ann N Y Acad Sci (1998) 1.00
Human skin: an independent peripheral endocrine organ. Horm Res (2000) 0.99
In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. FASEB J (2001) 0.98
The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology (1998) 0.97
Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology (1999) 0.97
Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol (2002) 0.97
The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress. Arch Dermatol (2003) 0.96
Regulation of melanocortin 1 receptor expression at the mRNA and protein levels by its natural agonist and antagonist. FASEB J (2003) 0.93
Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone. J Immunol (1997) 0.90
Detection of melanocortin-1 receptor antigenicity on human skin cells in culture and in situ. Exp Dermatol (1999) 0.87
[Acanthosis nigricans, papillomatosis mucosae and "tripe palms" in a patient with metastasized gastric carcinoma]. Dtsch Med Wochenschr (2006) 0.87
Messenger RNAs for the multifunctional cytokines interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor-alpha are present in adnexal tissues and in dermis of normal human skin. Exp Dermatol (1995) 0.86
Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol (2003) 0.86
Sebaceous glands in acne patients express high levels of neutral endopeptidase. Exp Dermatol (2002) 0.85
Peroxisome proliferator-activated receptors and skin development. Horm Res (2000) 0.84
Alpha-melanocyte stimulating hormone cytoprotective biology in human dermal fibroblast cells. Peptides (2005) 0.82
Proopiomelanocortin peptides and sebogenesis. Ann N Y Acad Sci (2003) 0.80
Neuropeptides and skin disorders. The new frontiers of neuro-endocrine-cutaneous immunology. Int J Dermatol (1999) 0.80
Androgens affect the activity of human sebocytes in culture in a manner dependent on the localization of the sebaceous glands and their effect is antagonized by spironolactone. Skin Pharmacol (1994) 0.79
Characterization of a polyclonal antibody raised against the human melanocortin-1 receptor. Ann N Y Acad Sci (1999) 0.79
alpha-Melanocyte stimulating hormone downregulates differentiation-driven heat shock protein 70 expression in keratinocytes. J Invest Dermatol (1997) 0.78
Receptors of eccrine, apocrine, and holocrine skin glands. Dermatol Clin (2007) 0.77
Expression of melanocortin-1 receptor in normal, malformed and neoplastic skin glands and hair follicles. Exp Dermatol (2002) 0.77
Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med (2012) 3.14
New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol (2009) 2.16
Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect (2006) 1.91
The treatment of chronic recurrent oral aphthous ulcers. Dtsch Arztebl Int (2014) 1.86
Steroidogenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol (2013) 1.71
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. Arch Dermatol (2007) 1.59
A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria. Infect Immun (2005) 1.55
Hydroxychloroquine modulates metabolic activity and proliferation and induces autophagic cell death of human dermal fibroblasts. J Invest Dermatol (2009) 1.55
Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat Cell Biol (2002) 1.48
Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol (2009) 1.44
Human sebaceous tumors harbor inactivating mutations in LEF1. Nat Med (2006) 1.40
New insights into the functions of alpha-MSH and related peptides in the immune system. Ann N Y Acad Sci (2003) 1.37
Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol (2009) 1.35
Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial. Arch Dermatol (2004) 1.33
Frontiers in sebaceous gland biology and pathology. Exp Dermatol (2008) 1.27
Malignant atrophic papulosis (Köhlmeier-Degos disease) - a review. Orphanet J Rare Dis (2013) 1.25
Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression. J Invest Dermatol (2009) 1.23
Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med (Berl) (2005) 1.23
Characterization of bipotential epidermal progenitors derived from human sebaceous gland: contrasting roles of c-Myc and beta-catenin. Stem Cells (2008) 1.22
Advanced glycation end products: Key players in skin aging? Dermatoendocrinol (2012) 1.20
13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy. Am J Pathol (2005) 1.17
Peroxidated squalene induces the production of inflammatory mediators in HaCaT keratinocytes: a possible role in acne vulgaris. J Invest Dermatol (2006) 1.17
Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma. J Invest Dermatol (2004) 1.11
Intralesional Cryotherapy for the Treatment of Keloid Scars: A Prospective Study. Plast Reconstr Surg (2015) 1.10
Alpha-melanocyte-stimulating hormone counteracts the suppressive effect of UVB on Nrf2 and Nrf-dependent gene expression in human skin. Endocrinology (2009) 1.10
Characterization of the vitamin D endocrine system in human sebocytes in vitro. J Steroid Biochem Mol Biol (2008) 1.08
Processing of procollagen III by meprins: new players in extracellular matrix assembly? J Invest Dermatol (2010) 1.07
Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol (2010) 1.07
Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill propionibacterium acnes. J Invest Dermatol (2008) 1.06
alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma? Arthritis Rheum (2009) 1.06
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol (2006) 1.06
Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J Invest Dermatol (2005) 1.05
Cutaneous androgen metabolism: basic research and clinical perspectives. J Invest Dermatol (2002) 1.05
Skin anti-aging strategies. Dermatoendocrinol (2012) 1.05
Vaccination targeting a surface sialidase of P. acnes: implication for new treatment of acne vulgaris. PLoS One (2008) 1.04
Expression of lipogenic factors galectin-12, resistin, SREBP-1, and SCD in human sebaceous glands and cultured sebocytes. J Invest Dermatol (2007) 1.04
Increased cAMP levels modulate transforming growth factor-beta/Smad-induced expression of extracellular matrix components and other key fibroblast effector functions. J Biol Chem (2009) 1.04
Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations. PLoS One (2011) 1.04
[Epidemiology and clinical manifestations of Adamantiades-Behçet disease in Germany -- current pathogenetic concepts and therapeutic possibilities]. J Dtsch Dermatol Ges (2006) 1.02
An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol (2011) 1.02
Neuroendocrine regulation of sebocytes -- a pathogenetic link between stress and acne. Exp Dermatol (2004) 1.01
Identification of platelet-activating factor acetylhydrolase II in human skin. J Invest Dermatol (2002) 1.01
Age-specific hormonal decline is accompanied by transcriptional changes in human sebocytes in vitro. Aging Cell (2006) 1.01
The skin as a mirror of the aging process in the human organism--state of the art and results of the aging research in the German National Genome Research Network 2 (NGFN-2). Exp Gerontol (2007) 1.01
Bioengineering a humanized acne microenvironment model: proteomics analysis of host responses to Propionibacterium acnes infection in vivo. Proteomics (2008) 1.01
Differentiation and apoptosis in human immortalized sebocytes. J Invest Dermatol (2003) 1.00
Atypical fibroxanthoma-a diagnosis of exclusion! Wien Med Wochenschr (2013) 1.00
Transient receptor potential vanilloid-1 signaling as a regulator of human sebocyte biology. J Invest Dermatol (2008) 0.99
Involvement of PPARgamma in oxidative stress-mediated prostaglandin E(2) production in SZ95 human sebaceous gland cells. J Invest Dermatol (2006) 0.98
Follicular drug eruption induced by gefitinib (ZD 1839, iressa): clinical picture correlates with in vitro data of focal epidermal necrosis after epidermal growth factor inhibition in skin cultures. Dermatology (2005) 0.98
Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol (2002) 0.97
A practical guide for the study of human and murine sebaceous glands in situ. Exp Dermatol (2013) 0.97
Skin and brain age together: The role of hormones in the ageing process. Exp Gerontol (2010) 0.97
Potential role of FoxO1 and mTORC1 in the pathogenesis of Western diet-induced acne. Exp Dermatol (2013) 0.95
Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital. Eur J Dermatol (2010) 0.95
Sebaceous glands as the primary target of EGFR-inhibitors in the development of papulopustular eruption. J Dermatol Sci (2012) 0.94
BP230- and BP180-specific auto-antibodies in bullous pemphigoid. J Invest Dermatol (2004) 0.94
Reactive hyperplasias,precancerous and malignant lesions of the oral mucosa. J Dtsch Dermatol Ges (2008) 0.93
Treating acne with antibiotic-resistant bacterial colonization. Expert Opin Pharmacother (2011) 0.93
Underestimated clinical features of postadolescent acne. J Am Acad Dermatol (2010) 0.92
Genome-wide pooling approach identifies SPATA5 as a new susceptibility locus for alopecia areata. Eur J Hum Genet (2011) 0.92
Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a. J Rheumatol (2008) 0.91
Anti-acne agents attenuate FGFR2 signal transduction in acne. J Invest Dermatol (2009) 0.91
Investigation of micronized titanium dioxide penetration in human skin xenografts and its effect on cellular functions of human skin-derived cells. Exp Dermatol (2008) 0.91
Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance. J Invest Dermatol (2012) 0.91
Genomic gain of 5p15 leads to over-expression of Misu (NSUN2) in breast cancer. Cancer Lett (2009) 0.91
Solar-simulated ultraviolet radiation-induced upregulation of the melanocortin-1 receptor, proopiomelanocortin, and alpha-melanocyte-stimulating hormone in human epidermis in vivo. J Invest Dermatol (2004) 0.91
Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling. FASEB J (2008) 0.90
Identification of biomarkers of human skin ageing in both genders. Wnt signalling - a label of skin ageing? PLoS One (2012) 0.90
Differential regulation of Toll-like receptor and CD14 pathways by retinoids and corticosteroids in human sebocytes. Dermatology (2006) 0.90
William J. Cunliffe Scientific Awards. Characteristics and pathomechanisms of endogenously aged skin. Dermatology (2007) 0.90
Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARgamma activation. Exp Dermatol (2010) 0.90
The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alpha-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components. Arthritis Rheum (2009) 0.89
Expression of S100A8/A9 in HaCaT keratinocytes alters the rate of cell proliferation and differentiation. FEBS Lett (2010) 0.89
A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. Arch Dermatol (2003) 0.89
PGD2 induces eotaxin-3 via PPARγ from sebocytes: a possible pathogenesis of eosinophilic pustular folliculitis. J Allergy Clin Immunol (2011) 0.89
Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks. BMC Genomics (2015) 0.89
Genetic variants in CTLA4 are strongly associated with alopecia areata. J Invest Dermatol (2011) 0.89
Zileuton, a new efficient and safe systemic anti-acne drug. Dermatoendocrinol (2009) 0.88
Androgens and ageing of the skin. Curr Opin Endocrinol Diabetes Obes (2009) 0.88
HAN11 binds mDia1 and controls GLI1 transcriptional activity. J Dermatol Sci (2006) 0.88
Intralesional cryosurgery enhances the involution of recalcitrant auricular keloids: a new clinical approach supported by experimental studies. Wound Repair Regen (2006) 0.88
Skin aging and sex hormones in women -- clinical perspectives for intervention by hormone replacement therapy. Exp Dermatol (2004) 0.87
Characterization of liver X receptor expression and function in human skin and the pilosebaceous unit. Exp Dermatol (2007) 0.87
TNF-α increases lipogenesis via JNK and PI3K/Akt pathways in SZ95 human sebocytes. J Dermatol Sci (2011) 0.87
A 3D QSAR study on a set of dopamine D4 receptor antagonists. J Chem Inf Comput Sci (2003) 0.86
Targeting of sebocytes by aminolevulinic acid-dependent photosensitization. Photochem Photobiol (2006) 0.86
Terminal signal: anti-inflammatory effects of α-melanocyte-stimulating hormone related peptides beyond the pharmacophore. Adv Exp Med Biol (2010) 0.86
Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol (2003) 0.86
The DNA-mismatch repair enzyme hMSH2 modulates UV-B-induced cell cycle arrest and apoptosis in melanoma cells. J Invest Dermatol (2007) 0.86
Doxorubicin-induced alopecia is associated with sebaceous gland degeneration. J Invest Dermatol (2006) 0.85
Regulation of constitutive and UVR-induced skin pigmentation by melanocortin 1 receptor isoforms. FASEB J (2006) 0.85
Sebaceous gland in human skin--the fantastic future of a skin appendage. J Invest Dermatol (2003) 0.85
Association of ustekinumab and briakinumab with major adverse cardiovascular events: An appraisal of meta-analyses and industry sponsored pooled analyses to date. Dermatoendocrinol (2012) 0.84